Mucosal and cutaneous human papillomavirus infections and cancer biology

T Gheit - Frontiers in Oncology, 2019 - frontiersin.org
Papillomaviridae is a family of small non-enveloped icosahedral viruses with double-
stranded circular DNA. More than 200 different human papillomaviruses (HPVs) have been …

Human papillomaviruses; epithelial tropisms, and the development of neoplasia

N Egawa, K Egawa, H Griffin, J Doorbar - Viruses, 2015 - mdpi.com
Papillomaviruses have evolved over many millions of years to propagate themselves at
specific epithelial niches in a range of different host species. This has led to the great …

Global burden of human papillomavirus and related diseases

D Forman, C de Martel, CJ Lacey, I Soerjomataram… - Vaccine, 2012 - Elsevier
The worldwide prevalence of infection with human papillomavirus (HPV) in women without
cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern …

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

H Ali, B Donovan, H Wand, TRH Read, DG Regan… - Bmj, 2013 - bmj.com
Objective To measure the effect on genital warts of the national human papillomavirus
vaccination programme in Australia, which started in mid-2007. Design Trend analysis of …

2019 IUSTI‐Europe guideline for the management of anogenital warts

R Gilson, D Nugent, RN Werner… - Journal of the …, 2020 - Wiley Online Library
This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

Papillomaviruses: Viral evolution, cancer and evolutionary medicine

IG Bravo, M Félez-Sánchez - Evolution, medicine, and public …, 2015 - academic.oup.com
Papillomaviruses (PVs) are a numerous family of small dsDNA viruses infecting virtually all
mammals. PVs cause infections without triggering a strong immune response, and natural …

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

T Palmer, L Wallace, KG Pollock, K Cuschieri… - bmj, 2019 - bmj.com
Objective To quantify the effect on cervical disease at age 20 years of immunisation with
bivalent human papillomavirus (HPV) vaccine at age 12-13 years. Design Retrospective …

Vaccines for HPV-associated diseases

JM Skolnik, MP Morrow - Molecular Aspects of Medicine, 2023 - Elsevier
Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …

Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme

EPF Chow, TRH Read, R Wigan, B Donovan… - Sexually transmitted …, 2015 - sti.bmj.com
Background Australia has provided free quadrivalent human papillomavirus (HPV) vaccines
to school girls since mid-2007 and a catch-up programme in the community to women aged …

Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach

JML Brotherton, SL Murray, MA Hall… - Medical Journal of …, 2013 - Wiley Online Library
Objective: To describe quadrivalent human papillomavirus (HPV) vaccination coverage
achieved in the HPV vaccination catch‐up program for girls aged 12–17 years. Design …